Literature DB >> 8904860

Cystic fibrosis deaths in the United States from 1979 through 1991. An analysis using multiple-cause mortality data.

C S Halliburton1, D M Mannino, R S Olney.   

Abstract

OBJECTIVE: To analyze mortality trends among people who died with a diagnosis of cystic fibrosis from January 1, 1979, through December 31, 1991.
METHODS: We reviewed death certificate reports in the Multiple-Cause Mortality Files compiled by the National Center for Health Statistics.
RESULTS: Of the 26,866,600 decedents in the study period, 6500 had a diagnosis of cystic fibrosis listed on their death certificates; of these, 6014 (92.5%) had cystic fibrosis listed as the underlying cause of death. The age-adjusted mortality rate decreased 21%, from 2.4 per 1 million in 1979 to 1.9 per 1 million in 1991, with similar decrements among males and females. The median age of death increased from 15 years in 1979 to 23 years in 1991. During the study period, whites were 6 times more likely to die with a diagnosis of cystic fibrosis than were blacks, and 8 times more likely than were people of other races. Comorbid conditions mentioned on death certificates included obstructive lung disease in 744 (11.5%), pneumonia in 1192 (18.3%), and right heart failure in 986 (15.2%).
CONCLUSIONS: From 1979 through 1991, the age-adjusted mortality rate for cystic fibrosis decreased and the median age of death among decedents with a diagnosis of cystic fibrosis increased. These results probably are due to improved treatment of the disease in children, although we cannot exclude other explanations for these findings, such as changes in death certification and coding or better diagnosis of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8904860     DOI: 10.1001/archpedi.1996.02170360071012

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  7 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Deanna M Green; J Michael Collaco; Kathryn E McDougal; Kathleen M Naughton; Scott M Blackman; Garry R Cutting
Journal:  J Pediatr       Date:  2012-02-23       Impact factor: 4.406

3.  Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000.

Authors:  J R Panickar; S R Dodd; R L Smyth; J M Couriel
Journal:  Thorax       Date:  2005-09-02       Impact factor: 9.139

Review 4.  Musculoskeletal and neuromuscular interventions: a physical approach to cystic fibrosis.

Authors:  Mary Massery
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

5.  Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.

Authors:  Deanna M Green; Kathryn E McDougal; Scott M Blackman; Patrick R Sosnay; Lindsay B Henderson; Kathleen M Naughton; J Michael Collaco; Garry R Cutting
Journal:  Respir Res       Date:  2010-10-08

6.  Cystic fibrosis mortality trends in Spain among infants and young children: 1981-2004.

Authors:  Enrique Ramalle-Gomara; Milagros Perucha; María-Angeles González; Carmen Quiñones; Jesús Andrés; Manuel Posada
Journal:  Eur J Epidemiol       Date:  2008-06-13       Impact factor: 8.082

7.  Mortality Due to Cystic Fibrosis over a 36-Year Period in Spain: Time Trends and Geographic Variations.

Authors:  Ana Villaverde-Hueso; Germán Sánchez-Díaz; Francisco J Molina-Cabrero; Elisa Gallego; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Int J Environ Res Public Health       Date:  2019-01-04       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.